Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruixin Wang

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
The British Journal of Ophthalmology|February 24, 2023
Incidence of and risk factors for suspected and definitive glaucoma after bilateral congenital cataract surgery: a 5-year follow-upJinghui Wang, Xianghua Wu, Qiwei Wang, et al.
American Journal of Public Health|April 28, 2022
Improving Data Surveillance Resilience Beyond COVID-19: Experiences of Primary heAlth Care quAlity Cohort In ChinA (ACACIA) Using Unannounced Standardized PatientsDong Roman Xu, Yiyuan Cai, Xiaohui Wang, et al.
The British Journal of Ophthalmology|May 21, 2020
Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional studyXiayin Zhang, Hui Xiao, Chunxin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 29, 2021
Co-Targeting Plk1 and DNMT3a in Advanced Prostate CancerZhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Cell Reports|July 5, 2024
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosisYanquan Zhang, Ka-Wing Fong, Fengyi Mao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 15, 2022
Co-Targeting Plk1 and DNMT3a in Advanced Prostate CancerZhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, et al.
Cell Reports|September 1, 2024
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironmentZhiwen Luo, Jie Mei, Xianwen Wang, et al.
Plos Genetics|November 21, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancerXiongjian Rao, Derek B Allison, Robert M Flight, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
The British Journal of Ophthalmology|February 24, 2023
Incidence of and risk factors for suspected and definitive glaucoma after bilateral congenital cataract surgery: a 5-year follow-upJinghui Wang, Xianghua Wu, Qiwei Wang, et al.
American Journal of Public Health|April 28, 2022
Improving Data Surveillance Resilience Beyond COVID-19: Experiences of Primary heAlth Care quAlity Cohort In ChinA (ACACIA) Using Unannounced Standardized PatientsDong Roman Xu, Yiyuan Cai, Xiaohui Wang, et al.
The British Journal of Ophthalmology|May 21, 2020
Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional studyXiayin Zhang, Hui Xiao, Chunxin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 29, 2021
Co-Targeting Plk1 and DNMT3a in Advanced Prostate CancerZhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Cell Reports|July 5, 2024
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosisYanquan Zhang, Ka-Wing Fong, Fengyi Mao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 15, 2022
Co-Targeting Plk1 and DNMT3a in Advanced Prostate CancerZhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, et al.
Cell Reports|September 1, 2024
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironmentZhiwen Luo, Jie Mei, Xianwen Wang, et al.
Plos Genetics|November 21, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancerXiongjian Rao, Derek B Allison, Robert M Flight, et al.
Pageof 22